Adenoviruses were first developed as expression vectors in the 1970’s by Dr. Frank Graham and his colleagues at McMaster University. Microbix collaborates extensively with Dr. Graham, providing us with access to the leading edge of Ad vector production technology and vector design. We have developed recombinant adenoviruses for gene delivery and vaccine purposes for many years, and benefit from access to technologies such as Dr. Graham’s popular AdMaxTM Cre-lox/FLP-frt based system for rapid, high-efficiency Ad vector construction.
Through our technical and quality systems we provide the level of service and technical support that our customers require for adenovirus based research and production. Our adenovirus vectors, cells and services have been purchased by over 600 companies and researchers around the world. We have been providing adenovirus services for the past 8 years, forming lasting partnerships with many of the major biopharmaceutical and biotechnology researchers and companies.
We are committed to delivering technologies and service will help you advance your molecular virology, from laboratory scale to the clinic. Thank you for your interest in Microbix’ portfolio of Adenovirus Technologies and best wishes for your Research and Development efforts.